Benefits firms shouldn't play drug favorites: CEO By: CNBC.com News January 20, 2015 at 08:48 AM EST Regeneron Pharmaceuticals CEO Dr. Leonard Schleifer told CNBC on Tuesday that benefits companies should not try to practice medicine. Read More >> Related Stocks: AbbVie Amgen Express Scripts Holding Gilead Sciences Regeneron Pharmaceuticals